Study on Single Nucleotide Polymorphisms of Functional Proteins determining Absorption, Metabolism, and Excretion of Edoxaban
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2019
Price : $35 *
At a glance
- Drugs Edoxaban (Primary)
- Indications Cardiovascular disorders; Stroke
- Focus Pharmacodynamics; Pharmacogenomic
- 31 Jan 2019 Status changed from not yet recruiting to recruiting.
- 27 Oct 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.
- 04 Oct 2017 New trial record